Other
Arteriosclerosis
4
Pipeline Programs↗
1
Active Trials↗
5
Companies Involved↗
Arteriosclerosis is an early-stage landscape with 4 programs across 5 companies. The most active players are Guangzhou Yipinhong Pharmaceutical CO.,LTD, Sanofi, Novartis. 2 therapies are approved with 1 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 1
No programs
Phase 2
No programs
Phase 31
Approved2
Analysis
Trial Status
3
clinical trials
Terminated1 · 33%
Unknown status1 · 33%
Active, not recruiting1 · 33%
Clinical Trials
Trial Activity
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)